North America Quadriplegia Care Devices Market by Product Type, End-Use, and Country-wise Insights: Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has recently released a detailed report on the North American quadriplegia care devices market. The report provides an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges, offering a comprehensive overview of the market structure.

Key Insights:

Quadriplegia Care Devices Market Size (2024E): USD 623.9 Mn
Projected Market Value (2031F): USD 813.6 Mn
North American Market Growth Rate (CAGR 2024 to 2031): 3.0%

Quadriplegia Care Devices Market - Report Scope:

Quadriplegia care devices are essential for improving the quality of life for individuals with quadriplegia by providing support and enhancing daily living activities. These devices include a range of assistive technologies such as wheelchairs, robotic exoskeletons, and communication aids. The North American market for these devices is driven by advancements in technology, increased prevalence of quadriplegia due to accidents and medical conditions, and growing awareness of the need for enhanced care solutions.

Market Growth Drivers:

The North American quadriplegia care devices market is driven by several factors, including the rising incidence of spinal cord injuries and neurological disorders that result in quadriplegia. Technological advancements in assistive devices, such as improvements in robotic exoskeletons and smart wheelchairs, contribute to market growth by offering better functionality and comfort. Increased funding for research and development, along with government initiatives and healthcare reforms focusing on disability care, further support the expansion of the market. Additionally, a growing aging population with mobility issues drives demand for innovative care solutions.

Market Restraints:

Despite its promising growth, the quadriplegia care devices market faces challenges such as high costs associated with advanced technologies and the complexity of integrating new devices into existing care systems. The expense of cutting-edge devices can be a significant barrier for patients and healthcare providers, particularly in regions with limited healthcare budgets. Additionally, the need for regular maintenance and updates of these devices can affect the overall cost of ownership. Regulatory hurdles and the need for compliance with stringent healthcare standards can also pose challenges for market participants.

Market Opportunities:

The North American quadriplegia care devices market presents substantial growth opportunities driven by ongoing technological innovations and increasing patient demand for personalized care solutions. Advances in telemedicine and remote monitoring technologies offer new possibilities for managing quadriplegia care more effectively. Expanding partnerships with healthcare providers, investment in R&D for new device functionalities, and exploring emerging markets within North America can provide significant growth avenues. The development of cost-effective and user-friendly solutions will also be crucial in capturing a larger share of the market.

Key Questions Answered in the Report:

What are the primary drivers of growth in the North American quadriplegia care devices market?
Which types of quadriplegia care devices are experiencing the highest adoption rates in the region?
How are technological advancements shaping the competitive landscape of the quadriplegia care devices market?
Who are the leading players in the North American quadriplegia care devices market, and what strategies are they implementing to stay competitive?
What are the emerging trends and future prospects in the North American quadriplegia care devices market?

Competitive Intelligence and Business Strategy:

Key players in the North American quadriplegia care devices market, including companies such as Invacare Corporation, ReWalk Robotics, and Otto Bock Healthcare, are focusing on innovation, strategic partnerships, and market expansion to maintain their competitive edge. These companies are investing in R&D to develop advanced care solutions, including next-generation wheelchairs and exoskeletons, to meet the diverse needs of patients. Collaborations with healthcare providers and research institutions facilitate market access and promote technology adoption. Emphasizing product reliability, patient comfort, and cutting-edge technology is essential for reinforcing the position of leading players in this evolving market.

Key Companies Profiled:

ReWalk Robotics
Ekso Bionics
Indego (Parker Hannifin Corporation)
Rex Bionics Ltd.
Caltech
Ossur
Steeper, Inc.
Boston Scientific corporation
Medtronic Plc.
Ottobock
RGK Wheelchairs
Rifton Equipment
Allard USA, Inc.
Fillauer LLC
College Park Industries
Mobius Bionics.
Parker Hannifin
Nevro
ProBed Medical Technologies Inc.
BLUE CHIP MEDICAL
Restorative Therapies
MYOLYN, LLC

Key Segments in North America Quadriplegia Care Devices Industry Survey

North America Quadriplegia Care Devices Market by Product:

Stimulation Devices
Assistive Devices
Mobility Devices
Hospital Beds
Transfer Bench and Boards
Braces & Supports
Orthopaedic Splints
Others Supportive Devices

North America Quadriplegia Care Devices Market by Indication:

Incomplete Quadriplegia
Complete Quadriplegia

North America Quadriplegia Care Devices Market by End User:

Rehabilitation Centres
Assistive Living Facilities
Long-term Care Centers
Home Care Settings

North America Quadriplegia Care Devices Market by Country:

U.S Quadriplegia Care Devices Market
Canada Quadriplegia Care Devices Market

Product Code: PMRREP33058

1. Executive Summary

1.1. North America Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion & Exclusion

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Trends in Diverse Applications

4. Market Background

4.1. Macro-Economic Factors
- 4.1.1. Increasing government support for the medical device sector
- 4.1.2. Improved economic conditions leading to increased penetration by companies
- 4.1.3. Rise in R&D spending
4.2. Forecast Factors - Relevance & Impact
- 4.2.1. Product Launches
- 4.2.2. R&D expenditure by key players
- 4.2.3. Degree of Technology advancements
- 4.2.4. Adoption Rate
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunity Analysis

5. Market Context

5.1. Emerging Technologies for Support & Care
5.2. Regulatory Scenario
5.3. PESTLE Analysis
5.4. PORTERS Analysis
5.5. Key Manufacturer's Promotional Strategies

6. COVID19 Crisis Analysis

6.1. Current GDP Projection and Probable Impact
6.2. Current Economic Projection as compared to 2008 financial analysis
6.3. COVID19 and Impact Analysis
- 6.3.1. Revenue by Products
- 6.3.2. Revenue by Indication
- 6.3.3. Revenue by End User
- 6.3.4. Revenue by Country
6.4. 2024 Market Scenario

7. North America Quadriplegia Care Devices Market Demand (in Units) Analysis 2019-2023 and Forecast, 2024-2031

7.1. Historical Market Volume (in Units) Analysis, 2019-2023
7.2. Current and Future Market Volume (in Units) Projections, 2024-2031
- 7.2.1. Y-o-Y Growth Trend Analysis

8. Quadriplegia Care Devices Market -Pricing Analysis

8.1. Regional Pricing Analysis by Indication
8.2. Pricing Break-up
- 8.2.1. Manufacturer Level Pricing
- 8.2.2. Distributor Level Pricing
8.3. Average Pricing Analysis Benchmark

9. North America Quadriplegia Care Devices Market Value (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
- 9.2.1. Y-o-Y Growth Trend Analysis
- 9.2.2. Absolute $ Opportunity Analysis

10. North America Quadriplegia Care Devices Market Analysis 2019-2023 and Forecast 2024-2031, by Products

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis and Volume in Units) By Products, 2019-2023
10.3. Current and Future Market Size (US$ Mn) and Volume in Units) Analysis and Forecast by Products, 2024-2031
- 10.3.1. Stimulation Devices
  - 10.3.1.1. Spinal cord Stimulators
  - 10.3.1.2. Functional Electrical Stimulation (FES) Systems
- 10.3.2. Assistive Devices
  - 10.3.2.1. Exoskeletons
  - 10.3.2.2. Robotic Arm Systems
  - 10.3.2.3. Prosthetics
    - 10.3.2.3.1. Upper Limb Prosthetics
    - 10.3.2.3.2. Lower Limb Prosthetics
- 10.3.3. Mobility Devices
  - 10.3.3.1. Wheelchairs
  - 10.3.3.2. Crutches & Walkers
  - 10.3.3.3. Gait Trainers
- 10.3.4. Hospital Beds
- 10.3.5. Transfer Bench and Boards
- 10.3.6. Braces & Supports
- 10.3.7. Orthopaedic Splints
- 10.3.8. Others Supportive Devices
10.4. Market Attractiveness Analysis by Products

11. North America Quadriplegia Care Devices Market Analysis 2019-2023 and Forecast 2024-2031, by Indication

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2024-2031
- 11.3.1. Incomplete quadriplegia
- 11.3.2. Complete quadriplegia
11.4. Market Attractiveness Analysis by Indication

12. North America Quadriplegia Care Devices Market Analysis 2019-2023 and Forecast 2024-2031, by End User

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2031
- 12.3.1. Hospitals
- 12.3.2. Rehabilitation Centres
- 12.3.3. Assistive Living Facilities
- 12.3.4. Long Term Care Centres
- 12.3.5. Home Care Settings
12.4. Market Attractiveness Analysis by End User

13. US Quadriplegia Care Devices Market Analysis 2019-2023 and Forecast 2024-2031

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
13.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
- 13.3.1. By Products
- 13.3.2. By Indication
- 13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis

14. Canada Quadriplegia Care Devices Market Analysis 2019-2023 and Forecast 2024-2031

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
14.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
- 14.3.1. By Products
- 14.3.2. By Indication
- 14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis

15. Competition Analysis

15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Competition Deep Dive
- 15.3.1. ReWalk Robotics
  - 15.3.1.1. Overview
  - 15.3.1.2. Product Portfolio
  - 15.3.1.3. Key Financials
  - 15.3.1.4. Recent Developments
  - 15.3.1.5. Sales Footprint
  - 15.3.1.6. Strategy Overview
    - 15.3.1.6.1. Marketing Strategy
    - 15.3.1.6.2. Product Strategy
    - 15.3.1.6.3. Channel Strategy
- 15.3.2. Ekso Bionics
  - 15.3.2.1. Overview
  - 15.3.2.2. Product Portfolio
  - 15.3.2.3. Key Financials
  - 15.3.2.4. Recent Developments
  - 15.3.2.5. Sales Footprint
  - 15.3.2.6. Strategy Overview
    - 15.3.2.6.1. Marketing Strategy
    - 15.3.2.6.2. Product Strategy
    - 15.3.2.6.3. Channel Strategy
- 15.3.3. Indego (Parker Hannifin Corporation)
  - 15.3.3.1. Overview
  - 15.3.3.2. Product Portfolio
  - 15.3.3.3. Key Financials
  - 15.3.3.4. Recent Developments
  - 15.3.3.5. Sales Footprint
  - 15.3.3.6. Strategy Overview
    - 15.3.3.6.1. Marketing Strategy
    - 15.3.3.6.2. Product Strategy
    - 15.3.3.6.3. Channel Strategy
- 15.3.4. Rex Bionics Ltd.
  - 15.3.4.1. Overview
  - 15.3.4.2. Product Portfolio
  - 15.3.4.3. Key Financials
  - 15.3.4.4. Recent Developments
  - 15.3.4.5. Sales Footprint
  - 15.3.4.6. Strategy Overview
    - 15.3.4.6.1. Marketing Strategy
    - 15.3.4.6.2. Product Strategy
    - 15.3.4.6.3. Channel Strategy
- 15.3.5. Caltech
  - 15.3.5.1. Overview
  - 15.3.5.2. Product Portfolio
  - 15.3.5.3. Key Financials
  - 15.3.5.4. Recent Developments
  - 15.3.5.5. Sales Footprint
  - 15.3.5.6. Strategy Overview
    - 15.3.5.6.1. Marketing Strategy
    - 15.3.5.6.2. Product Strategy
    - 15.3.5.6.3. Channel Strategy
- 15.3.6. Ossur
  - 15.3.6.1. Overview
  - 15.3.6.2. Product Portfolio
  - 15.3.6.3. Key Financials
  - 15.3.6.4. Recent Developments
  - 15.3.6.5. Sales Footprint
  - 15.3.6.6. Strategy Overview
    - 15.3.6.6.1. Marketing Strategy
    - 15.3.6.6.2. Product Strategy
    - 15.3.6.6.3. Channel Strategy
- 15.3.7. Steeper, Inc.
  - 15.3.7.1. Overview
  - 15.3.7.2. Product Portfolio
  - 15.3.7.3. Key Financials
  - 15.3.7.4. Recent Developments
  - 15.3.7.5. Sales Footprint
  - 15.3.7.6. Strategy Overview
    - 15.3.7.6.1. Marketing Strategy
    - 15.3.7.6.2. Product Strategy
    - 15.3.7.6.3. Channel Strategy
- 15.3.8. Boston Scientific corporation
  - 15.3.8.1. Overview
  - 15.3.8.2. Product Portfolio
  - 15.3.8.3. Key Financials
  - 15.3.8.4. Recent Developments
  - 15.3.8.5. Sales Footprint
  - 15.3.8.6. Strategy Overview
    - 15.3.8.6.1. Marketing Strategy
    - 15.3.8.6.2. Product Strategy
    - 15.3.8.6.3. Channel Strategy
- 15.3.9. Medtronic Plc.
  - 15.3.9.1. Overview
  - 15.3.9.2. Product Portfolio
  - 15.3.9.3. Key Financials
  - 15.3.9.4. Recent Developments
  - 15.3.9.5. Sales Footprint
  - 15.3.9.6. Strategy Overview
    - 15.3.9.6.1. Marketing Strategy
    - 15.3.9.6.2. Product Strategy
    - 15.3.9.6.3. Channel Strategy
- 15.3.10. Ottobock
  - 15.3.10.1. Overview
  - 15.3.10.2. Product Portfolio
  - 15.3.10.3. Key Financials
  - 15.3.10.4. Recent Developments
  - 15.3.10.5. Sales Footprint
  - 15.3.10.6. Strategy Overview
    - 15.3.10.6.1. Marketing Strategy
    - 15.3.10.6.2. Product Strategy
    - 15.3.10.6.3. Channel Strategy
- 15.3.11. RGK Wheelchairs
  - 15.3.11.1. Overview
  - 15.3.11.2. Product Portfolio
  - 15.3.11.3. Key Financials
  - 15.3.11.4. Recent Developments
  - 15.3.11.5. Sales Footprint
  - 15.3.11.6. Strategy Overview
    - 15.3.11.6.1. Marketing Strategy
    - 15.3.11.6.2. Product Strategy
    - 15.3.11.6.3. Channel Strategy
- 15.3.12. Rifton Equipment
  - 15.3.12.1. Overview
  - 15.3.12.2. Product Portfolio
  - 15.3.12.3. Key Financials
  - 15.3.12.4. Recent Developments
  - 15.3.12.5. Sales Footprint
  - 15.3.12.6. Strategy Overview
    - 15.3.12.6.1. Marketing Strategy
    - 15.3.12.6.2. Product Strategy
    - 15.3.12.6.3. Channel Strategy
- 15.3.13. Allard USA, Inc.
  - 15.3.13.1. Overview
  - 15.3.13.2. Product Portfolio
  - 15.3.13.3. Key Financials
  - 15.3.13.4. Recent Developments
  - 15.3.13.5. Sales Footprint
  - 15.3.13.6. Strategy Overview
    - 15.3.13.6.1. Marketing Strategy
    - 15.3.13.6.2. Product Strategy
    - 15.3.13.6.3. Channel Strategy
- 15.3.14. Fillauer LLC
  - 15.3.14.1. Overview
  - 15.3.14.2. Product Portfolio
  - 15.3.14.3. Key Financials
  - 15.3.14.4. Recent Developments
  - 15.3.14.5. Sales Footprint
  - 15.3.14.6. Strategy Overview
    - 15.3.14.6.1. Marketing Strategy
    - 15.3.14.6.2. Product Strategy
    - 15.3.14.6.3. Channel Strategy
- 15.3.15. College Park Industries
  - 15.3.15.1. Overview
  - 15.3.15.2. Product Portfolio
  - 15.3.15.3. Key Financials
  - 15.3.15.4. Recent Developments
  - 15.3.15.5. Sales Footprint
  - 15.3.15.6. Strategy Overview
    - 15.3.15.6.1. Marketing Strategy
    - 15.3.15.6.2. Product Strategy
    - 15.3.15.6.3. Channel Strategy
- 15.3.16. Mobius Bionics.
  - 15.3.16.1. Overview
  - 15.3.16.2. Product Portfolio
  - 15.3.16.3. Key Financials
  - 15.3.16.4. Recent Developments
  - 15.3.16.5. Sales Footprint
  - 15.3.16.6. Strategy Overview
    - 15.3.16.6.1. Marketing Strategy
    - 15.3.16.6.2. Product Strategy
    - 15.3.16.6.3. Channel Strategy
- 15.3.17. Parker Hannifin
  - 15.3.17.1. Overview
  - 15.3.17.2. Product Portfolio
  - 15.3.17.3. Key Financials
  - 15.3.17.4. Recent Developments
  - 15.3.17.5. Sales Footprint
  - 15.3.17.6. Strategy Overview
    - 15.3.17.6.1. Marketing Strategy
    - 15.3.17.6.2. Product Strategy
    - 15.3.17.6.3. Channel Strategy
- 15.3.18. Nevro
  - 15.3.18.1. Overview
  - 15.3.18.2. Product Portfolio
  - 15.3.18.3. Key Financials
  - 15.3.18.4. Recent Developments
  - 15.3.18.5. Sales Footprint
  - 15.3.18.6. Strategy Overview
    - 15.3.18.6.1. Marketing Strategy
    - 15.3.18.6.2. Product Strategy
    - 15.3.18.6.3. Channel Strategy
- 15.3.19. ProBed Medical Technologies Inc.
  - 15.3.19.1. Overview
  - 15.3.19.2. Product Portfolio
  - 15.3.19.3. Key Financials
  - 15.3.19.4. Recent Developments
  - 15.3.19.5. Sales Footprint
  - 15.3.19.6. Strategy Overview
    - 15.3.19.6.1. Marketing Strategy
    - 15.3.19.6.2. Product Strategy
    - 15.3.19.6.3. Channel Strategy
- 15.3.20. BLUE CHIP MEDICAL
  - 15.3.20.1. Overview
  - 15.3.20.2. Product Portfolio
  - 15.3.20.3. Key Financials
  - 15.3.20.4. Recent Developments
  - 15.3.20.5. Sales Footprint
  - 15.3.20.6. Strategy Overview
    - 15.3.20.6.1. Marketing Strategy
    - 15.3.20.6.2. Product Strategy
    - 15.3.20.6.3. Channel Strategy
- 15.3.21. Restorative Therapies
  - 15.3.21.1. Overview
  - 15.3.21.2. Product Portfolio
  - 15.3.21.3. Key Financials
  - 15.3.21.4. Recent Developments
  - 15.3.21.5. Sales Footprint
  - 15.3.21.6. Strategy Overview
    - 15.3.21.6.1. Marketing Strategy
    - 15.3.21.6.2. Product Strategy
    - 15.3.21.6.3. Channel Strategy
- 15.3.22. MYOLYN, LLC
  - 15.3.22.1. Overview
  - 15.3.22.2. Product Portfolio
  - 15.3.22.3. Key Financials
  - 15.3.22.4. Recent Developments
  - 15.3.22.5. Sales Footprint
  - 15.3.22.6. Strategy Overview
    - 15.3.22.6.1. Marketing Strategy
    - 15.3.22.6.2. Product Strategy
    - 15.3.22.6.3. Channel Strategy